Financial News
Latest News about AXSM
Recent news which mentions AXSM
Axsome's Solriamfetol Fails Primary Goal In Depression Study But Shows Improvements In Associated Sleep Disorder
April 01, 2025
From Benzinga
From Benzinga
Why Pharma and Biotech Stocks Got Thrashed on Tuesday
March 25, 2025
From Motley Fool
Axsome Therapeutics Lower Dose Of Attention Deficient Disorder Candidate Hits Primary Goal
March 25, 2025
From Benzinga
Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs
February 24, 2025
From Benzinga
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
February 18, 2025
From Benzinga
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
February 18, 2025
From Benzinga
Axsome Therapeutics (AXSM) Q4 2024 Earnings Call Transcript
February 18, 2025
Tickers
AXSM
From Motley Fool
Earnings Scheduled For February 18, 2025
February 18, 2025
From Benzinga
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
From Benzinga
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
February 16, 2025
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 10, 2025
From Benzinga
Beyond The Numbers: 17 Analysts Discuss Axsome Therapeutics Stock
February 10, 2025
Tickers
AXSM
From Benzinga
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'
February 10, 2025
From Benzinga
Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday
February 10, 2025
From Benzinga
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
December 31, 2024
From Benzinga
Expert Outlook: Axsome Therapeutics Through The Eyes Of 8 Analysts
December 30, 2024
Tickers
AXSM
From Benzinga
Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
December 30, 2024
From Benzinga
Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
November 27, 2024
From Benzinga
Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript
November 12, 2024
Tickers
AXSM
From Motley Fool
A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
November 12, 2024
Tickers
AXSM
From Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
From Benzinga
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
October 19, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
